Companies โ€บ Lux Biosciences

Lux Biosciences

Healthcare ๐Ÿ“ Jersey City, United States ๐Ÿ‘ฅ 501-1000 employees ๐Ÿ’ฐ $90.2M raised ๐Ÿ“… Founded 2005

Lux Biosciences, Inc., a biotechnology company, develops medications to treat ophthalmic diseases. Its products include LX201, a silicone matrix ocular implant that enables the release of cyclosporine A to the eye for one year; Luveniq, an oral form of calcineurin inhibitor voclosporin; LX212, a bioerodible polymer imp

๐Ÿ“Š Company Overview

Sector
Healthcare
Country
United States
Employees
501-1000
Total Raised ยท Debt
$90.2M
Founded
2005
Cloud
Unknown

โ˜๏ธ Cloud Infrastructure

Workspace๐Ÿ”’ Subscribers only
CDN๐Ÿ”’ Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

๐Ÿ’ฐ Estimated Cloud Spend

$3M โ€“ $7M / year across cloud providers

๐Ÿ›  Tech Stack & Marketing

Ad Platforms๐Ÿ”’ Subscribers only
Analytics & CRM๐Ÿ”’ Subscribers only
CMS / Platform๐Ÿ”’ Subscribers only
Frontend Stack๐Ÿ”’ Subscribers only

Detected from Lux Biosciences's public homepage as of 2026-06-13.

๐Ÿ” Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 ยท Methodology ยท Suggest a correction